Delivery Order SPE2DB20D3303-SPE2DB25FA3QA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/ml ampules under a firm fixed-price contract valued at $1,191.06. The award was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under an existing contract vehicle, reflecting the agency's...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules. This non-competitive delivery order, issued on August 5, 2025, represents a firm fixed-price purchase under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. As a leading pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $1,198.90 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules, with an ultimate completion date of August 29, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules, with a contract ceiling value of $2,078.12. The award, issued on August 18, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. Performance will be executed from the company's location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating the award resulted from open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Epinephrine 1 mg/mL ampules, valued at $1,311.41. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is scheduled for completion by August 21, 2025,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Epinephrine 1 MG/ML Ampuls with a ceiling value of $2,637.68 under a firm fixed price contract type. The delivery order was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded contract that represents a child order under AmerisourceBergen's larger federal contract vehicle with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,194.57 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 12, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was issued to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Epinephrine 1 mg/mL ampules, valued at $2,807.85. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion by September 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order,...
- The Defense Logistics Agency awarded a $1,069.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for 0.15 mg epinephrine auto-injectors (2-pack) on September 3, 2025, with completion targeted for September 4, 2025. This non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $3,366.00 delivery order to AmerisourceBergen Drug Corp for Epinephrine 1 mg/mL ampules on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside contract employs firm fixed price terms and is being performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a small-value transaction within AmerisourceBergen's broader federal medical supply portfolio and...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3QADelivery Order
The Defense Logistics Agency (DLA) awarded a $1,013.53 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/ml ampules under a firm fixed price contract. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was not set aside and was competitively awarded, demonstrating AmerisourceBergen's continued capability to fulfill federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. As a leading pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems globally. The company's contract portfolio with DLA encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, enabling service to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/12/25 |